FolioLanternBeta
MIRMMirum Pharmaceuticals, Inc.

Eric Bjerkholt

Chief Financial Officer at Mirum Pharmaceuticals, Inc., as of Sep 15, 2026Sold $3.6M of stock in the past 12 months: 47% under a disclosed plan and 53% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
45K
shares held after the latest filing, Mirum Pharmaceuticals, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
36K
shares sold, past 12 months
7
days with sales
$978K
largest single day, Sep 14, 2026
1
company filed for

Share of stake sold at Mirum Pharmaceuticals, Inc. is not shown: the same shares may be reported by another insider. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJan 2026: $234K to cover taxesJanFebMar 2026: $670K to cover taxesMarAprMayJun 2026: $469K under a disclosed planJunJul 2026: $611K under a disclosed planJulAug 2026: $600K under a disclosed planAugSep 2026: $978K to cover taxes$978KSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Mirum Pharmaceuticals, Inc. (MIRM)Chief Financial OfficerSep 12, 2023Sep 15, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.